Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non-randomized controlled trial.

IF 4 Q1 CLINICAL NEUROLOGY
Pablo M Bagnati, Marisol Londoño Castaño, María Laura Fernández, Beatriz Mora Henao, Patricio Chrem, David Aguillón, Luz Estela Varela, Juan Diego Barbaran, Yudy Leon, Ezequiel Surace, Claudia C Madrigal, Juan Pablo Picasso, Claudia P Ramos, Carlos M Restrepo Fernández, Gabriela Vigo, Laura Ramirez Aguilar, Gabriel Alberto VargasCuadros, Mauricio Arcos-Burgos, Erika Mariana Longoria, Ellen Ziegemeier, Eric McDade, Randall J Bateman, Ricardo F Allegri, Francisco Lopera, Jorge J Llibre-Guerra
{"title":"Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non-randomized controlled trial.","authors":"Pablo M Bagnati, Marisol Londoño Castaño, María Laura Fernández, Beatriz Mora Henao, Patricio Chrem, David Aguillón, Luz Estela Varela, Juan Diego Barbaran, Yudy Leon, Ezequiel Surace, Claudia C Madrigal, Juan Pablo Picasso, Claudia P Ramos, Carlos M Restrepo Fernández, Gabriela Vigo, Laura Ramirez Aguilar, Gabriel Alberto VargasCuadros, Mauricio Arcos-Burgos, Erika Mariana Longoria, Ellen Ziegemeier, Eric McDade, Randall J Bateman, Ricardo F Allegri, Francisco Lopera, Jorge J Llibre-Guerra","doi":"10.1002/dad2.70102","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study involved evaluating a tailored genetic counseling and testing (GCT) protocol for families at risk of autosomal dominant Alzheimer's disease (ADAD) in Latin America (LatAm), focusing on essential cultural and regional adaptations.</p><p><strong>Methods: </strong>We conducted a non-randomized controlled trial among ADAD families in Colombia and Argentina. Participants were categorized based on their decision to learn their genetic status (GS), with further comparisons between mutation-positive versus mutation-negative participants who learned their status. Psychological impacts were measured using validated scales for anxiety and depression.</p><p><strong>Results: </strong>Of the 122 eligible participants, 97 completed the GCT protocol, and 87 opted to learn their GS. There were no clinically significant differences in psychological distress between those who learned their status and those who did not, nor between mutation-positive and mutation-negative individuals.</p><p><strong>Discussion: </strong>The GCT protocol effectively managed psychological impacts in ADAD families and was positively received, demonstrating the importance of culturally adapted GCT protocols.</p><p><strong>Highlights: </strong>We examined the adaptation and efficacy of a GCT protocol in LatAm for families at risk of ADAD.The GCT protocol mitigated psychological distress among at-risk ADAD families.The study confirms the protocol's cultural appropriateness and psychological safety.Future studies should explore the long-term psychological and public health impacts of GCT and use of GCT for treatment options.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"17 2","pages":"e70102"},"PeriodicalIF":4.0000,"publicationDate":"2025-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11973255/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study involved evaluating a tailored genetic counseling and testing (GCT) protocol for families at risk of autosomal dominant Alzheimer's disease (ADAD) in Latin America (LatAm), focusing on essential cultural and regional adaptations.

Methods: We conducted a non-randomized controlled trial among ADAD families in Colombia and Argentina. Participants were categorized based on their decision to learn their genetic status (GS), with further comparisons between mutation-positive versus mutation-negative participants who learned their status. Psychological impacts were measured using validated scales for anxiety and depression.

Results: Of the 122 eligible participants, 97 completed the GCT protocol, and 87 opted to learn their GS. There were no clinically significant differences in psychological distress between those who learned their status and those who did not, nor between mutation-positive and mutation-negative individuals.

Discussion: The GCT protocol effectively managed psychological impacts in ADAD families and was positively received, demonstrating the importance of culturally adapted GCT protocols.

Highlights: We examined the adaptation and efficacy of a GCT protocol in LatAm for families at risk of ADAD.The GCT protocol mitigated psychological distress among at-risk ADAD families.The study confirms the protocol's cultural appropriateness and psychological safety.Future studies should explore the long-term psychological and public health impacts of GCT and use of GCT for treatment options.

遗传咨询和检测对拉丁美洲家族性阿尔茨海默病高风险个体的影响:一项非随机对照试验
导言:本研究旨在评估针对拉丁美洲常染色体显性遗传性阿尔茨海默病(ADAD)高风险家庭量身定制的遗传咨询和检测(GCT)方案,重点关注基本的文化和地区适应性:我们在哥伦比亚和阿根廷的 ADAD 家庭中开展了一项非随机对照试验。我们根据参与者是否决定了解自己的基因状况(GS)对他们进行了分类,并对了解自己基因状况的突变阳性参与者与突变阴性参与者进行了进一步比较。心理影响则使用经过验证的焦虑和抑郁量表进行测量:在 122 名符合条件的参与者中,97 人完成了 GCT 方案,87 人选择了解自己的基因状态。在得知自己病情的参与者和未得知病情的参与者之间,以及在基因突变阳性和基因突变阴性个体之间,心理困扰没有临床意义上的差异:讨论:GCT方案有效地控制了ADAD家庭的心理影响,并获得了积极的反响,这表明了根据文化调整GCT方案的重要性:该研究证实了该方案的文化适宜性和心理安全性。未来的研究应探讨 GCT 对心理和公共健康的长期影响,以及使用 GCT 的治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.80
自引率
7.50%
发文量
101
审稿时长
8 weeks
期刊介绍: Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信